Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
Authors:
- Chia-Yen DaiChia-Yen Dai
- Wan-Long ChuangWCWan-Long Chuang
- Li-Po LeeLLLi-Po Lee
- Jee-Fu HuangJHJee-Fu Huang
- Nai-Jen HouNHNai-Jen Hou
- Zu-Yau LinZLZu-Yau Lin
- Shinn-Cherng ChenSCShinn-Cherng Chen
- Ming-Yuh HsiehMHMing-Yuh Hsieh
- Liang-Yen WangLWLiang-Yen Wang
- Jun-Fa TsaiJTJun-Fa Tsai
- Wen-Yu ChangWCWen-Yu Chang
- Ming-Lung YuMing-Lung Yu
- 1 August 2007
- journal article
- clinical trial
- Published by Elsevier in Antiviral Research
- Vol. 75 (2) , 146-151
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Variant of Hepatitis B Virus with Primary Resistance to AdefovirNew England Journal of Medicine, 2006
- Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutantsJournal of Viral Hepatitis, 2006
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensationJournal of Hepatology, 2005
- Activity of adefovir dipivoxil against all patterns of lamivudine‐resistant hepatitis B viruses in patientsJournal of Viral Hepatitis, 2005
- Chronic hepatitis B: Update of recommendations† ‡Hepatology, 2004
- Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in TaiwanJournal of Clinical Pathology, 2004
- 382 In vitro characterization and molecular modeling analysis of a novel adefovir resistance mutation RTN236T in the HBV polymeraseJournal of Hepatology, 2004
- Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeksHepatology, 2002
- Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapyHepatology, 1998
- From Hepatitis to Hepatoma: Lessons from Type B Viral HepatitisScience, 1993